"Our mission is to preserve the native structure of membrane proteins to improve the performance and reliability of drugs, antibodies, vaccines and diagnostic tools"

Dr Emmanuel DEJEAN, CALIXAR Chairman and CEO

ABOUT CALIXAR

CALIXAR offers a unique and patented technological platform allowing to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High Throughput Screening assays.

PRESS RELEASES